[Federal Register Volume 85, Number 96 (Monday, May 18, 2020)]
[Notices]
[Pages 29720-29723]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10598]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 85 FR 21008, dated April 15, 2020) is amended
to reorganize the National Center for Immunization and Respiratory
Diseases, Centers for Disease Control and Prevention.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete mission statements for the National Center for Immunization
and Respiratory Diseases (CVG) insert the following:
National Center for Immunization and Respiratory Diseases (CVG).
The National Center for Immunization and Respiratory Diseases (NCIRD)
prevents disease, disability, and death through immunization and by
control of respiratory and related diseases. In carrying out its
mission, NCIRD: (1) Provides leadership, expertise, and service in
laboratory and epidemiological sciences, and in immunization program
delivery; (2) conducts applied research on disease prevention and
control; (3) translates research findings into public health policies
and practices; (4) provides diagnostic and reference laboratory
services to relevant partners; (5) conducts surveillance and research
to determine disease distribution, determinants, and burden nationally
and internationally; (6) responds to disease outbreaks domestically and
abroad; (7) ensures that public health decisions are made objectively
and based upon the highest quality of scientific data; (8) provides
technical expertise, education, and training to domestic and
international partners; (9) provides leadership to internal and
external partners for establishing and
[[Page 29721]]
maintaining immunization, and other prevention and control programs;
(10) develops, implements, and evaluates domestic and international
public health policies; (11) communicates information to increase
awareness, knowledge, and understanding of public health issues
domestically and internationally, and to promote effective immunization
programs; (12) aligns the national center focus with the overall
strategic goals of CDC; (13) synchronizes all aspects of CDC's pandemic
influenza preparedness and response from strategy through
implementation and evaluation; and (14) implements, coordinates, and
evaluates programs across NCIRD, Deputy Director for Infectious
Diseases(DDID), and CDC to optimize public health impact.
Delete the functional statements for the Office of the Director
(CVG1) and insert the following:
Office of the Director (CVG1). (1) Provides leadership, expertise,
and service in laboratory and epidemiological sciences and in
immunization program delivery; (2) provides diagnostic and reference
laboratory services to relevant partnerships; (3) works with DDID to
ensure spending plans, budget planning, and budget execution are in
line with the overall infectious disease strategies and priorities; (4)
ensures that the NCIRD strategy is executed by the divisions and
aligned with overall CDC goals; (5) co-develops execution strategies
for the center with the division directors; (6) provides program and
science quality oversight; (7) builds leadership at the division and
branch levels; (8) evaluates the strategies, focus, and prioritization
of the division research, program, and budget activities; (9)
identifies and coordinates synergies between center and relevant
partners; (10) ensures that policy development is consistent and
appropriate; (11) facilitates research and program activities by
providing leadership support; (12) proposes resource priorities
throughout the budget cycle; (13) ensures scientific quality, ethics,
and regulatory compliance; (14) fosters an integrated approach to
research, program, and policy activities; (15) liaises with HHS and
other domestic and international immunization and respiratory disease
partners as well as with NCIRD divisions; (16) coordinates center's
emergency response activities related to immunization issues and
complex acute respiratory infectious disease emergencies; (17) applies
communication science, media principles, and web design to support
NCIRD and CDC's efforts to reduce morbidity and mortality caused by
vaccine-preventable and respiratory diseases; ensuring that
communication distributed by the center is timely, accurate, clear and
relevant to intended audiences; (18) provides guidance for key
scientific and laboratory services in the functional areas of
extramural research (research and non-research), human studies
oversight and review, regulatory affairs; activities in the area of
space planning, advising, coordination and evaluation, safety
management and coordination, and shared services in controlled
correspondence, and programmatic services in the area of workforce and
career development; (19) provides and coordinates center-wide
administrative, management, and support services in the areas of fiscal
management, personnel, travel, procurement, facility management, the
Vaccine Management Improvement Project and other administrative
services; and (20) manages the coordination of workforce development
and succession planning activities and provide human capital
management, planning and training consultation services.
Delete the functional statements for the Office of Informatics
(CVG12) and insert the following:
Office of Informatics (CVG12). (1) Manages all IT project costs,
schedules, performances, and risks; (2) provides expertise in leading
application development techniques in information science and
technology to affect the best use of resources; (3) performs technical
evaluation and/or integrated baseline reviews of all information
systems' products and services prior to procurement to ensure software
purchases align with DDID strategy; (4) provides access to quality data
in support of programmatic data analysis; (5) coordinates all
enterprise-wide IT security policies and procedures with the Office of
the Chief Information Officer; (6) ensures operations are in accordance
with CDC Capital Planning and Investment Control guidelines; (7)
ensures adherence to CDC enterprise architecture guidelines and
standards; (8) consults with users to determine IT needs and to develop
strategic and action plans; and (9) participates in the evolution,
identification, development, or adoption of appropriate informatics
standards in conjunction with the DDID.
Delete in its entirety the title and functional statement for the
Office of Administrative Services (CVG16) and insert the following:
Office of Management and Operations (CVG16). (1) Plans,
coordinates, directs and provides advice and guidance on management and
administrative operations of NCIRD in the areas of fiscal management,
personnel, human capital, workforce training and development, travel,
records management, facility management and other administrative
related services; (2) prepares and distributes annual budget plans and
provides overall programmatic direction for planning and management
oversight of allocated resources; (3) provides guidance on NCIRD
requirements related to contracts, grants, cooperative agreements,
reimbursable agreements, interagency agreements, memorandums of
agreement/understanding, and intergovernmental personnel act
agreements; (4) reviews the effectiveness and efficiency of the
operation and administration of all NCIRD programs; (5) develops and
implements administrative policies and procedures; and (6) prepares
special reports and studies in the administrative management areas.
Delete in its entirety the title and functional statement for the
Office of Science and Integrated Programs (CVG17) and insert the
following:
Office of Science (CVG17). (1) Links strategies and priorities of
the primarily programmatic-focused NCIRD divisions with those of
primarily disease-based divisions; (2) facilitates development and
ongoing implementation of integrated infectious respiratory disease
(including influenza) surveillance, research, and prevention and
control activities across the divisions, both domestically and
globally, including supporting implementation of NCIRD's respiratory
diseases strategic prevention priorities; (3) interfaces with other CDC
CIOs working in the area of respiratory diseases; (4) coordinates and
facilitates the center's overall respiratory and vaccine preventable
disease scientific/research agenda; (5) assumes responsibility for the
protection of human research subjects, scientific review, clearance of
manuscripts and other written materials; (6) provides planning and
coordination of overall surveillance strategies, preparedness,
response, and prevention effectiveness related to a center-wide public
health scientific agenda and in quantifying how programs and activities
promote cost-effective and high impact prevention strategies with
respect to immunization and other vaccine preventable disease programs;
(7) provides leadership (agency and center-wide) for vaccine
preventable and respiratory disease surveillance to include guidance
and coordination of NCIRD surveillance activities and systems, as well
as leadership on issues related to internal and external integration of
CDC surveillance
[[Page 29722]]
activities; (8) coordinates, facilitates and integrates domestic and
international respiratory and vaccine preventable disease surveillance
activities through existing methods while developing new approaches,
tools and analyses for these activities; (9) fosters a
multidisciplinary approach to epidemiology, statistics, informatics,
laboratory methods and evaluation; (10) provides leadership, expertise
and service in laboratory science; (11) represents NCIRD's interests in
cross-cutting laboratory services in DDID which include, but are not
limited to, laboratory information systems, quality management systems
and bioinformatics; (12) ensures a safe working environment in NCIRD
laboratories; (13) collaborates effectively with other centers and
offices in carrying out its functions; and (14) manages CDC's
intellectual property (e.g., patents, trademarks, copyrights) and
promotes the transfer of new technology from CDC research to the
private sector to facilitate and enhance the development of diagnostic
products, vaccines, and products to improve occupational safety.
After the functional statement for the Influenza Coordination Unit
(CVG18), insert the following:
VTrckS Management Office (CVG19). Responsible for providing day-to-
day management and support for VTrckS/NABIP internal and external
customers including: (1) Co-chair and support of VTrckS PMO; (2)
testing and troubleshooting of all VTrckS and NABIP functionality and
break fixes; (3) OCM and communications for internal and external
VTrckS and NABIP customers; (4) web-based and in person training for
internal and external VTrckS and NABIP customers; (5) conducting annual
VTrckS User Satisfaction survey; (6) Level 1 and Level 2 support for
VTrckS and NABIP; and (7) managing contracts for Business Analysts,
VTrckS operations and maintenance technical support, training and
program support, and VTrckS contact center operations.
Delete in its entirety the title and functional statement for the
Division of Bacterial Diseases (CVGG) and insert the following:
Division of Bacterial Diseases (CVGG). The Division of Bacterial
Diseases (DBD) prevents respiratory and vaccine-preventable diseases
caused by bacteria through strategic planning, coordination, scientific
investigation, and leadership. In carrying out its mission, DBD: (1)
Conducts and assists state and local health departments to conduct
surveillance, including surveillance for antimicrobial resistance in
the bacteria under the Division's purview, and prepares and distributes
surveillance information; (2) conducts epidemiologic and laboratory
studies to define etiology, patterns of disease, disease burden, and
risk factors; determines safety, effectiveness, and cost effectiveness
of vaccines, updates immunization policy, and evaluates other aspects
of immunization practices; and identifies and evaluates other (non-
vaccine) prevention strategies; (3) provides consultation on the use of
bacterial vaccines and other measures to prevent infections; (4)
participates, provides consultation, and supports investigations of
outbreaks, epidemics, and other public health problems in the U.S. and
internationally, and recommends and evaluates appropriate control
measures; (5) provides scientific leadership for development and
evaluation of immunization policy related to vaccines in the U.S. by
compiling and analyzing information on vaccine-preventable diseases and
helping prepare statements on bacterial vaccines for the ACIP and other
groups to support the development and evaluation of immunization
policy; in international settings, provides guidance and technical
expertise on VPD policy development; (6) provides laboratory support
for surveillance and epidemiologic studies and reference diagnostic
services, to state and local health departments, other federal
agencies, and national and international health organizations; (7)
conducts studies of the biology, biochemical, genetic, and antigenic
characteristics, immunology and pathogenesis of disease; (8) develops,
analyzes, and improves diagnostic methods and reagents; (9) facilitates
development and evaluation of immunologic compounds, vaccines and
vaccination programs; (10) provides intramural and extramural
assistance with professional training; (11) assists internal and
external partners with other public health problems of national and
international significance when needed; (12) provides technical support
to state immunization programs for all aspects of vaccine-preventable
diseases and their vaccines; (13) provides leadership in vaccine
science; and (14) supports CDC's Immunization Safety Office in vaccine
safety risk assessment and leadership in vaccine safety risk
management.
Office of the Director (CVGG1). (1) Directs, coordinates, and
manages the programs and activities of the division; (2) provides
leadership and guidance on policy, program planning and development,
program management, and operations; (3) coordinates or assures
coordination with the appropriate CDC, CCID, and NCIRD offices on
administrative and program matters; (4) reviews, prepares, and
coordinates congressional testimony and briefing documents related to
bacterial respiratory and vaccine preventable diseases, and analyzes
programmatic and policy implications of legislative proposals; (5)
serves as CDC, CCID, and NCIRD's primary internal and external
communications contact regarding bacterial respiratory and vaccine-
preventable disease issues; (6) advises CDC, CCID, and NCIRD on policy
matters concerning the division's programs and activities; (7) assures
the overall quality of the science conducted by the division; (8)
guides and facilitates efficient coordination and cooperation for
administrative, programmatic, and scientific activities within the
division, and with other groups in and outside of CDC; (9) provides
statistical methodology and participates in the division's outbreak
investigations and disease reporting systems for ongoing surveillance;
(10) develops new methods or adapts existing methods for statistical
applications in epidemiologic or laboratory research studies for the
division; (11) provides statistical consultation for epidemiologic and
laboratory research studies conducted by the division; (12) assists
researchers with statistical aspects of report writing and prepares
statistical portions of papers, protocols, and reports written by staff
of the division; (13) trains professional staff of the division in
statistical methods; and (14) provides a center of excellence for the
study of immunologic response to infection, vaccination, and
therapeutic interventions against bacterial diseases, including
Bacillus anthracis.
Respiratory Diseases Branch (CVGGB). (1) Provides assistance and
control of epidemics and works to improve control and prevention of
respiratory and other syndromes caused by Streptococcus pneumoniae,
group A and group B streptococci, and atypical respiratory bacteria
(Legionella, Mycoplasma, and Chlamydia species), as well as community-
acquired drug resistant bacterial infections, community-acquired
pneumonia, otitis media, and neonatal sepsis; (2) develops, implements,
and evaluates prevention methods for these diseases, including vaccines
and non-vaccine strategies; (3) provides consultation and support to
domestic and international partners on use of vaccines and other
prevention measures to reduce bacterial respiratory diseases; (4)
coordinates activities within and outside the division related to
Active Bacterial Core
[[Page 29723]]
surveillance with the Emerging Infections Program states, and assists
with coordination of other surveillance platforms that include
bacterial respiratory diseases; (5) provides reference and diagnostic
activities for respiratory bacterial diseases and for the
identification of unknown gram positive cocci; (6) develops and
evaluates new diagnostic methods for bacterial respiratory pathogens;
(7) develops, maintains, and implements genetic analyses of bacteria to
enhance surveillance programs, outbreak investigations, and public
health research; and (8) collaborates with other CDC groups, state and
federal agencies, ministries of health, WHO, PAHO, private industry,
academia, and other governmental organizations involved in public
health.
Meningitis and Vaccine Preventable Disease Branch (CVGGC). (1)
Provides assistance in control of endemic and epidemic disease and
exploits opportunities to improve control and prevention of bacterial
illness including: disease due to Neisseria meningitidis, Haemophilus
influenzae infections, diphtheria, pertussis, tetanus, and bacterial
meningitis syndrome; (2) provides reference and diagnostic activities
for agents causing these diseases; (3) provides cross-cutting vaccine
responsibilities for the division of bacterial diseases; and develops,
implements and evaluates prevention strategies for these bacterial
diseases; (4) develops, implements, and evaluates vaccines and vaccine
candidates for these bacterial diseases; (5) conducts surveillance and
epidemiological research for meningococcal disease, H. influenzae
infections, diphtheria, pertussis, tetanus, and bacterial meningitis
syndrome; (6) maintains WHO Collaborating Center for Control and
Prevention of Epidemic Meningitis; and (7) collaborates with other CDC
groups, state and federal agencies, ministries of health, WHO, PAHO,
private industry, and other governmental organizations involved in
public health
Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-10598 Filed 5-15-20; 8:45 am]
BILLING CODE 4163-18-P